Austria's Blood Centre Linz Purchases 454 Sequencer | GenomeWeb
NEW YORK (GenomeWeb News) – Roche announced today that the Blood Centre Linz, an Austrian research institute specializing in bone marrow and stem cell transplantation, has purchased a Roche 454 Genome Sequencer FLX System.
 
Blood Centre Linz plans to use the 454 sequencer to help match donors with recipients and to assist in research aimed at reducing the risk of rejection during bone marrow and stem cell transplants.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.